Transcend Capital Advisors, LLC Roivant Sciences Ltd. Transaction History
Transcend Capital Advisors, LLC
- $1.44 Billion
- Q3 2024
A detailed history of Transcend Capital Advisors, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 21,948 shares of ROIV stock, worth $266,009. This represents 0.02% of its overall portfolio holdings.
Number of Shares
21,948Holding current value
$266,009% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
311Shares Held
508MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$799 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$797 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$656 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$505 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$429 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.54B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...